Context TherapeuticsCNTX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 42 institutions reported holding Context Therapeutics Inc. (CNTX) in their 13F filings, up 8 from Q2 2024. 13 opened new positions and 6 sold out. The largest holders were Nextech Invest Ltd. ($14.5M), Deep Track Capital, LP ($14.5M) and Avidity Partners Management LP ($14.5M). 2 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Context Therapeutics Inc.
- CUSIP
- 21077P108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $7.2M |
| Exits | 6 | $5.4M |
All 13F filers, Q2 2024 → Q3 2024: 4,557,528 shares bought and 4,959,484 shares sold, net −401,956 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 42 holders
| Nextech Invest Ltd. | 2.04% | No change | 7,419,355 | $14.5M |
| Deep Track Capital, LP | 0.46% | No change | 7,419,355 | $14.5M |
| Avidity Partners Management LP | 0.74% | Reduce -0.0% | 7,417,155 | $14.5M |
| Great Point Partners LLC | 4.10% | Reduce -6.5% | 6,934,982 | $13.6M |
| Blue Owl Capital Holdings LP | 2.06% | Add +4.8% | 5,411,290 | $10.6M |
| Vanguard Group Inc. | 0.00% | Reduce -16.8% | 3,744,961 | $7.3M |
| Blackstone Inc. | 0.02% | Add +32.7% | 2,440,330 | $4.8M |
| Nantahala Capital Management, LLC | 0.32% | No change | 1,935,484 | $3.8M |
| Franklin Resources Inc. | 0.00% | New | 1,853,988 | $3.7M |
| Ally Bridge Group (NY) LLC | 1.84% | Reduce -6.8% | 1,757,524 | $3.4M |
| Alyeska Investment Group, L.P. | 0.02% | Reduce -14.0% | 1,663,655 | $3.3M |
| Woodline Partners LP | 0.02% | New | 1,360,682 | $2.7M |
| Sio Capital Management, LLC | 1.17% | No change | 1,328,352 | $2.6M |
| Affinity Asset Advisors, LLC | 0.43% | Reduce -18.4% | 1,321,153 | $2.6M |
| Velan Capital Investment Management LP | 2.75% | No change | 1,290,323 | $2.5M |
| BlackRock, Inc. | 0.00% | — | 848,970 | $1.7M |
| Geode Capital Management, LLC | 0.00% | Reduce -6.8% | 575,899 | $1.1M |
| ADAR1 Capital Management, LLC | 0.12% | Reduce -42.1% | 373,835 | $733K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 0.02% | Add +5.1% | 308,758 | $605K |
| Northern Trust Corp. | 0.00% | Reduce -1.1% | 172,511 | $338K |
| Millennium Management | 0.00% | New | 143,883 | $282K |
| HighTower Advisors, LLC | 0.00% | No change | 125,852 | $247K |
| State Street Corp. | 0.00% | Add +21.5% | 111,907 | $219K |
| Walleye Capital LLC | 0.00% | Add +1.2% | 109,655 | $215K |
| Mill Creek Capital Advisors, LLC | 0.00% | No change | 104,631 | $205K |
| Qube Research & Technologies Ltd | 0.00% | New | 103,405 | $203K |
| Renaissance Technologies | 0.00% | Add +1.2% | 66,000 | $129K |
| Susquehanna International Group, LLP | 0.00% | New | 54,211 | $106K |
| Aster Capital Management (DIFC) Ltd | 0.02% | — | 52,792 | $103K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 45,635 | $89K |
| Citigroup Inc. | 0.00% | New | 44,779 | $88K |
| Jefferies Financial Group Inc. | 0.00% | New | 43,200 | $85K |
| Clear Harbor Asset Management, LLC | 0.01% | No change | 36,000 | $71K |
| Caxton Corp. | 0.15% | No change | 18,403 | $36K |
| Two Sigma Investments, LP | 0.00% | No change | 13,844 | $27K |
| Bank of America Corp. | 0.00% | Reduce -5.4% | 10,192 | $20K |
| Cerity Partners LLC | 0.00% | New | 10,000 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,155 | $14K |
| UBS Group AG | 0.00% | New | 1,717 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 500 | $980 |
| AdvisorNet Financial, Inc | 0.00% | New | 200 | $392 |
| JPMorgan Chase & Co. | 0.00% | New | 173 | $339 |
"% of holder's portfolio" is CNTX's weight in each manager's 13F, not the share of Context Therapeutics Inc. the manager owns.